Mopec Group Company Profile

Background

Overview

Mopec Group, established in 1992 and headquartered in Madison Heights, Michigan, is a vertically integrated manufacturer and supplier specializing in high-quality anatomic and forensic pathology equipment, consumables, technologies, and services. The company serves a diverse clientele, including hospitals, universities, morgues, and various laboratories, aiming to enhance diagnostic accuracy, safety, research, education, and disease treatment.

Mission and Vision

Mission: To empower pathology and anatomy professionals by providing leading products and solutions that advance diagnostic accuracy, safety, research, education, and disease treatment.

Vision: To be the preferred choice for pathology and anatomy professionals worldwide.

Industry Significance

With over three decades of experience, Mopec Group has established itself as a key player in the pathology equipment sector, offering a comprehensive range of products that support the pathology continuum. The company's commitment to innovation and quality has made it a trusted partner for numerous healthcare institutions globally.

Key Strategic Focus

Core Objectives

Enhance operational efficiency through strategic consolidation and investment in advanced manufacturing capabilities.

Expand product offerings to include a comprehensive range of pathology solutions, encompassing equipment, consumables, and services.

Strengthen global presence by establishing international distribution channels and strategic partnerships.

Areas of Specialization

Anatomic and forensic pathology equipment.

Laboratory consumables and technologies.

Comprehensive pathology solutions for various laboratory environments.

Key Technologies Utilized

Advanced manufacturing automation.

Digital pathology integration.

AI-driven workflow optimization.

Primary Markets Targeted

Hospitals and medical centers.

Academic and research institutions.

Morgues and forensic laboratories.

Global pathology laboratories.

Financials and Funding

Funding History

2013: Acquired by Blackford Capital, a Michigan-based private equity firm.

2025: Acquired by Waud Capital Partners, a Chicago-based private equity firm specializing in healthcare and technology sectors.

Total Funds Raised

Specific details regarding the total funds raised are not publicly disclosed.

Notable Investors

Blackford Capital

Waud Capital Partners

Utilization of Capital

The capital from these investments has been utilized to:

Expand manufacturing capabilities.

Develop and integrate advanced technologies.

Support strategic acquisitions and partnerships.

Pipeline Development

Key Pipeline Candidates

Mopec Group focuses on developing a comprehensive range of pathology solutions, including:

Advanced grossing stations.

Digital pathology integration tools.

AI-driven diagnostic support systems.

Stages of Development

The company is in various stages of development, from conceptualization to market-ready products, with ongoing efforts to enhance existing offerings and introduce innovative solutions.

Target Conditions

Mopec's products are designed to support a wide array of conditions encountered in pathology, including:

Cancer diagnostics.

Forensic investigations.

General pathology examinations.

Anticipated Milestones

While specific timelines are not publicly disclosed, Mopec Group continues to invest in research and development to achieve significant milestones in product innovation and market expansion.

Technological Platform and Innovation

Proprietary Technologies

Maestro® Encore Grossing Stations: Advanced workstations designed to enhance specimen preparation efficiency and safety.

Digital Pathology Integration: Tools that facilitate the transition to digital pathology workflows, improving diagnostic accuracy and collaboration.

Significant Scientific Methods

AI-Driven Workflow Optimization: Utilizing artificial intelligence to streamline laboratory processes and support diagnostic decision-making.

Advanced Manufacturing Automation: Implementing automated systems to ensure precision and scalability in product manufacturing.

Leadership Team

Francis X. Dirksmeier | Chief Executive Officer

With a background in leading global manufacturing companies, Mr. Dirksmeier has been instrumental in driving Mopec Group's strategic growth and operational excellence.

Michael McClain | Chief Technology Officer

An expert in electromechanical and biomedical equipment design, Mr. McClain oversees the development and integration of Mopec's technological innovations.

Jeff Pemberton | Vice President of Marketing & Commercial Strategy

Mr. Pemberton leads marketing initiatives, focusing on brand development and market expansion strategies.

Lee Kramer | Vice President of Sales

Responsible for sales operations, Mr. Kramer drives revenue growth and customer relationship management.

Lorraine Marshall | Director of Human Resources

Ms. Marshall manages human resources, emphasizing talent development and organizational culture.

Scott Nudelman | Senior Director of Service, Warranty, & Quality

Mr. Nudelman ensures service excellence and product quality across Mopec's offerings.

Leadership Changes

In January 2025, Waud Capital Partners acquired Mopec Group, leading to strategic shifts and the appointment of new leadership to guide the company's growth trajectory.

Competitor Profile

Market Insights and Dynamics

The pathology equipment market is characterized by a growing demand for advanced diagnostic tools, digital integration, and workflow optimization. Key trends include the adoption of AI technologies and the expansion of global healthcare infrastructure.

Competitor Analysis

Aspen Surgical: A significant competitor offering a range of surgical instruments and pathology equipment.

Mortech Manufacturing: Specializes in pathology and mortuary equipment, providing solutions for specimen handling and storage.

TBJ: Offers a variety of medical equipment, including pathology instruments and laboratory furniture.

Strategic Collaborations and Partnerships

In May 2025, Mopec Group announced a strategic partnership with Lumea, a leader in digital pathology and AI-powered workflow innovation. This collaboration aims to integrate Lumea's BxCamera® into Mopec's Maestro® Encore grossing stations, enhancing diagnostic accuracy and workflow efficiency.

Operational Insights

Mopec Group's strategic consolidation of operations into its Michigan headquarters has streamlined manufacturing processes and improved operational efficiency. The establishment of a new distribution center in Troy, Michigan, further strengthens the company's ability to serve laboratories, hospitals, and research institutions across North America and globally.